After years of delays and debate, 2024 was the year when several health initiatives started to move forward. And advocates ...

However the company does have a SGLT2 drug, Farxiga, which could have a similar CV profile to Jardiance. In March, AstraZeneca announced an analysis of real world data from more than 300,000 ...

In contrast, only about 9% of folks without diabetes up to age 70 develop dementia. So, it's very welcome news that SGLT2 inhibitors, such as Farxiga, Jardiance, and Invokana, that are approved to ...

sources say "It is medically necessary that Jessica use Farxiga or Jardiance as part of her heart failure." But Horizon Blue Cross Blue Shield of New Jersey denied coverage for the medicine which ...

The quest for effective weight loss solutions has never been more urgent, with millions of people worldwide struggling to ...

SGLT2 inhibitors such as Jardiance and AstraZeneca’s Forxiga/Farxiga (dapagliflozin) are starting to make waves for their potential in treating chronic heart failure, but Boehringer and Lilly ...

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

"The negotiations included two pairs of drugs that belonged to the same drug class -- Eliquis [apixaban]/Xarelto [rivaroxaban] and Farxiga [dapagliflozin]/Jardiance [empagliflozin]. In each case ...

Ozempic's ads were 57% more effective in driving consumer engagement on streaming TV than on linear TV during Q3.

In a year when GLP-1 drugs were a best-selling, buzzy phenomenon, Novo Nordisk’s ad spend for Ozempic in streaming TV has been paying off. The brand’s ads were 57% more effective in driving ...